Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Notices 34719 

1The record is defined in § 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

TCL Industries Holdings Co., Ltd., 22nd 

Floor, TCL Technical Tower, Huifeng 

Third Road, Zhongkai Development 

Zone, Huizhou, Guangdong, China 

516006 

TCL Industries Holdings (H.K.) Limited, 

8th Floor, Building 22E, Phase Three, 

Hong Kong Science Park, Pak Shek 

Kok, New Territories, Hong Kong 

TCL Electronics Holdings Limited, 

f/k/a TCL Multimedia Technology 

Holdings, Ltd., 7/F, Building 22E, 22 

Science Park East Avenue, Hong Kong 

Science Park, Sha Tin, New 

Territories, Hong Kong 

TCL Technology Group Corporation, 

TCL Technology Building, No. 17, 

Huifeng Third Road, Zhongkai Hightech Zone, Huizhou, Guangdong, 

China 516006 

TTE Corporation, 7/F, Building 22E, 22 

Science Park East Avenue, Hong Kong 

Science Park, Sha Tin, New 

Territories, Hong Kong 

TCL Holdings (BVI) Limited, 5/F, 

Building 22E, 22 Science Park East 

Avenue, Hong Kong Science Park, Sha 

Tin, New Territories, Hong Kong 

TCL King Electrical Appliances 

(Huizhou) Co. Ltd., No. 78, Huifeng 

Fourth Road, Zhongkai Development 

Zone, Huizhou, Guangdong, China 

516006 

Shenzhen TCL New Technologies Co., 

Ltd., 9th Floor, TCL Electronics 

Holdings Limited Building, TCL 

International E City, No. 1001, 

Zhongshan Park Road, Nanshan 

District, Shenzhen, Guangdong, China 

518067 

TCL MOKA International Limited, 7/F 

Hong Kong Science Park, Building 22 

E, 22 Science Park East Avenue, Sha 

Tin, New Territories, Hong Kong 

TCL Smart Device (Vietnam) Co., Ltd., 

No. 26 VSIP II–A, Street 32, Vietnam, 

Singapore Industrial Park II–A, Tan 

Binh Commune, Bac Tan Uyen 

District, Binh Duong Province, 

Vietnam 75000 

Manufacturas Avanzadas SA de CV, 

Blvd. Independencia #2151, Parque 

Industrial Salvacar, Ciudad Jua ́rez, 

Chihuahua, Mexico 32574 

TCL Electronics Mexico, S de RL de CV, 

Av. Insurgentes Sur 1425, Insurgentes 

Mixcoac, Benito Juarez, Distrito 

Federal, Mexico 03920 

TCL Overseas Marketing Ltd., 5/F, 

Building 22E, 22 Science Park East 

Avenue, Hong Kong Science Park, Sha 

Tin, New Territories, Hong Kong 

Realtek Semiconductor Corp., No. 2, 

Innovation Road II, Hsinchu Science 

Park, Hsinchu 300, Taiwan 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not participate as a 

party to this investigation. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainants of 

the complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: June 1, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–12156 Filed 6–6–22; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–470–471 and 

731–TA–1169–1170 (Second Review)] 

Certain Coated Paper Suitable for 

High-Quality Print Graphics Using 

Sheet-Fed Presses From China and 

Indonesia 

Determination 

On the basis of the record 1 developed 

in the subject five-year reviews, the 

United States International Trade 

Commission (‘‘Commission’’) 

determines, pursuant to the Tariff Act of 

1930 (‘‘the Act’’), that revocation of the 

countervailing and antidumping duty 

orders on certain coated paper suitable 

for high-quality print graphics using 

sheet-fed presses from China and 

Indonesia would be likely to lead to 

continuation or recurrence of material 

injury to an industry in the United 

States within a reasonably foreseeable 

time. 

Background 

The Commission instituted these 

reviews on December 1, 2021 (86 FR 

68272) and determined on March 7, 

2022, that it would conduct expedited 

reviews (87 FR 22231, April 14, 2022). 

The Commission made these 

determinations pursuant to section 

751(c) of the Act (19 U.S.C. 1675(c)). It 

completed and filed its determinations 

in these reviews on June 2, 2022. The 

views of the Commission are contained 

in USITC Publication 5330 (June 2022), 

entitled Certain Coated Paper Suitable 

for High-Quality Print Graphics Using 

Sheet-Fed Presses from China and 

Indonesia (Inv. Nos. 701–TA–470–471 

and 731–TA–1169–1170 (Second 

Review)). 

By order of the Commission. 

Issued: June 2, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–12202 Filed 6–6–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1024] 

Bulk Manufacturer of Controlled 

Substances Application: Stepan 

Company 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Stepan Company has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 8, 2022. Such 

persons may also file a written request 


jspears on DSK121TN23PROD with NOTICES1
34720 Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Notices 

for a hearing on the application on or 

before August 8, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on February 2, 2022, 

Stepan Company, 100 West Hunter 

Avenue, Maywood, New Jersey 07607– 

1021, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Cocaine ..................................... 9041 II 

Ecgonine ................................... 9180 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates or for sale to its 

customers. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–12198 Filed 6–6–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1021] 

Bulk Manufacturer of Controlled 

Substances Application: Pisgah 

Laboratories Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Pisgah Laboratories Inc. has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 8, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before August 8, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on March 9, 2022, Pisgah 

Laboratories Inc., 3222 Old 

Hendersonville Highway, Pisgah Forest, 

North Carolina 28768, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug code Schedule 

4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................ 7392 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................ 7540 I 

Difenoxin ................................................................................................................................................................................ 9168 I 

Diphenoxylate ........................................................................................................................................................................ 9170 II 

Levorphanol ........................................................................................................................................................................... 9220 II 

Meperidine ............................................................................................................................................................................. 9230 II 

Methadone ............................................................................................................................................................................. 9250 II 

Remifentanil ........................................................................................................................................................................... 9739 II 

Tapentadol ............................................................................................................................................................................. 9780 II 

The company plans to bulk 

manufacture the above-listed controlled 

substances in bulk for distribution to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–12197 Filed 6–6–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Proposed Interim Settlement 

and Crediting Agreement Under 

Comprehensive Environmental 

Response, Compensation and Liability 

Act 

As of May 25, 2022, the United States 

Fish and Wildlife Service (‘‘USFWS’’), 

on behalf of the Department of the 

Interior, the National Oceanic and 

Atmospheric Administration 

(‘‘NOAA’’), on behalf of the Department 

of Commerce, (collectively, the 

‘‘Trustees’’), the Department of Justice, 

and potentially responsible party 

(‘‘PRP’’) BASF Corporation (‘‘BASF’’) 

signed a proposed non-judicial Interim 

Settlement and Crediting Agreement 

concerning early natural resource 

restoration work under the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act (‘‘CERCLA’’), 42 U.S.C. 9601 et seq., 

for a five-acre property in East Newark, 

New Jersey. The United States contends 

BASF and other PRPs are liable for 

natural resource damages under Section 

107(a) of CERCLA, 42 U.S.C. 9607(a), 

concerning the Diamond Alkali 

Superfund Site, including Newark Bay 

and the upstream 17 mile stretch of the 

Passaic River, and the Berry’s Creek 

Study Area, Bergen County, New Jersey 

(collectively ‘‘the Sites’’). The proposed 

agreement facilitates early natural 

resource restoration work, and provides 

for credit for accomplished early 

restoration work, in advance of the 


jspears on DSK121TN23PROD with NOTICES1